VLN® Products Launch in Nevada to Help Smokers Smoke Less

3 years ago

Terrible Herbst and Speedee Mart Selling VLN® Reduced Nicotine Products in Approximately 200 Las Vegas Area Stores FDA Authorized VLN®…

SciSparc Announces IRB Approval to Conduct its Phase IIb Trial in Tourette Syndrome

3 years ago

Company reaches another clinical trial milestone for treatment of Tourette’s with its novel SCI-110 therapy in the United States TEL…

Smart for Life Releases Corporate Video on Roger Conley Wood

3 years ago

Video Represents Latest in the Company’s “Director’s Forum” Series – Observations from the Company’s Independent DirectorsMIAMI, June 21, 2023 (GLOBE…

Eloxx Pharmaceuticals Highlights Recent Alport Syndrome Natural History Data Presented at 60th ERA Congress

3 years ago

Data from RaDaR natural history study indicates that Alport syndrome patients with autosomal recessive COL4A4 mutations have severest disease, with…

Earth Science Tech, Inc Shares a Letter from the CEO on Recently Filed March 31, 2023, YE Report

3 years ago

“You don’t have to be great to start, but you do have to start to be great!” Miami, FL, June…

Dyadic Announced an MoU with Bangladesh’s State-Owned Pharmaceutical Company to Facilitate Biopharmaceutical Research and Biomanufacturing Capacity

3 years ago

JUPITER, Fla. and DHAKA, Bangladesh, June 21, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the…

HMNC Brain Health to Participate in the Psychedelic Science Conference 2023 and the H.C. Wainwright & Co. 4th Annual Neuropsychiatry Conference

3 years ago

MUNICH, Germany, June 21, 2023 (GLOBE NEWSWIRE) -- HMNC Brain Health (“HMNC” or the “company”), a global clinical-stage biopharmaceutical company,…

Tumult Labs Helps Wikimedia Foundation Ensure Privacy of Detailed Data Usage Metrics

3 years ago

Differential Privacy Pioneer Supports Need to Share Granular, Country-level Data Publicly for the First Time without Compromising PrivacyDURHAM, N.C., June…

Women In Bio Connecticut hosts Panel at Yale Innovation Summit

3 years ago

WIB-CT How to Build a Better Board Erika Smith (left to right), CEO ReNetX, moderated WIB-CT’s How to Build a…

SAB Biotherapeutics Presents Positive IND-Enabling GLP Toxicology Study for SAB-142, a Novel Immunotherapeutic for Type 1 Diabetes at FOCIS 2023

3 years ago

SAB highlights results from GLP toxicology study confirming SAB-142's mechanism of action at the 23rd Federation of Clinical Immunology Societies…